Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7edddef6787c20d191842b48a0e2d150 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fefaa23997eadd3ae612ff105ecb1b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ec1f20e46b10ddc6a496ce7d1dc62af |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1774 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5767 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
filingDate |
2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248daa268cbb1946b8c08d2747e96e21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6901a1e568c4a5a3aaf8f9b4b911be1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4991de63961a53afd928ca406ac3cbec |
publicationDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012083458-A1 |
titleOfInvention |
Methods and compositions for detecting and treating inflammatory disease |
abstract |
The invention features methods of diagnosing inflammatory disease based on the elevated presence microparticles (MP) expressing certain receptors. The invention also features methods of decreasing fibrosis in the liver by administering MP to subjects with liver fibrosis. |
priorityDate |
2010-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |